ArticleJournal of intensive care2022

Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: a nationwide observational study.

Nobuyasu Awano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.